HIG.TO Brompton Global Healthcare Income & Growth ETF
This actively managed fund aims to provide consistent monthly income, capital appreciation, and reduced volatility. It achieves these goals by investing in a concentrated portfolio of 15 to 30 large, international healthcare companies that exhibit both strong value and growth characteristics. Companies are rigorously assessed beyond their market capitalization, with a focus on their valuation, growth prospects, profitability, liquidity, balance sheet strength, and dividend yield. Up to a quarter of the fund's assets may also be allocated to other healthcare-related businesses, provided they meet specific size requirements. To further enhance returns and temper overall portfolio risk, the fund manager strategically sells call options. This particular fund is an unhedged counterpart to HIG, with its units traded in U.S. dollars.
No price history on file.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| HIG.TO | +7.6% | +9.9% | +9.2% | +8.4% | +9.2% | +1.8% |
| Equity average (1460 funds) | -5.4% | -4.7% | +1.4% | +3.9% | +11.9% | +4.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$38K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| CVS CVS Health Corporation | 1.90% | $2.0M | $0 |
Holdings · as of Nov 15, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | LLY Eli Lilly and Company | 6.10% |
| 2 | GILD Gilead Sciences, Inc. | 6.00% |
| 3 | NVS Novartis AG ADR | 5.50% |
| 4 | JNJ Johnson & Johnson | 5.50% |
| 5 | HIG.TO Others | 5.20% |
| 6 | VRTX Vertex Pharmaceuticals Incorporated | 4.90% |
| 7 | MCK McKesson Corp. | 4.80% |
| 8 | MRK Merck & Co Inc. | 4.80% |
| 9 | CAH Cardinal Health, Inc. | 4.60% |
| 10 | UNH UnitedHealth Group Incorporated | 4.60% |
| 11 | HCA HCA Healthcare, Inc. | 4.50% |
| 12 | A Agilent Technologies Inc. | 4.40% |
| 13 | DHR Danaher Corporation | 3.90% |
| 14 | CI The Cigna Group | 3.80% |
| 15 | TMO Thermo Fisher Scientific Inc. | 3.70% |
| 16 | EW Edwards Lifesciences Corporation | 3.10% |
| 17 | AMGN Amgen Inc. | 3.00% |
| 18 | REGN Regeneron Pharmaceuticals, Inc. | 2.80% |
| 19 | AZN AstraZeneca PLC ADR | 2.80% |
| 20 | DGX Quest Diagnostics Inc. | 2.80% |
| 21 | BMY Bristol-Myers Squibb Company | 2.70% |
| 22 | GSK GSK PLC ADR | 2.60% |
| 23 | RO.SW Roche Holding AG | 2.10% |
| 24 | ISRG Intuitive Surgical, Inc. | 2.00% |
| 25 | WAT Waters Corp. | 1.90% |
| 26 | CVS CVS Health Corporation | 1.90% |
Sector breakdown
Not on file.
Country breakdown
Not on file.
Distributions
No distributions on file.
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in HIG.TO in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 16, 2026. This is historical data, not investment advice. Report a data error
